Pharmacovigilance

Pharmacovigilance is an activity aimed at identifying, evaluating, understanding, and preventing adverse effects of medicinal products.

One of our key objectives is to ensure that consumers receive high-quality, effective, and safe medicinal products, where the benefits outweigh the potential risks.

JSC "Ferane" is fully responsible for the quality and effectiveness of its medicines. A pharmacovigilance system has been established to provide continuous safety monitoring of our products.

The procedure for pharmacovigilance is regulated by the Good Pharmacovigilance Practice (GVP) Rules of the Eurasian Economic Union, approved by the Council of the Eurasian Economic Commission on 03.11.2016 No. 87.

If you have information about a suspected adverse reaction or lack of efficacy of any product manufactured by JSC "Ferane", please notify us:

• by email: pv@ferane.by;
• via WhatsApp, Viber, or Telegram: +375 (29) 674-35-58;
• via Instagram: @FARMAKONADZORFERANE;
• by phone (24/7): +375 (29) 674-35-58;
• by post: 220014, Minsk, per. S. Kovalevskaya, 52A;
• by filling out the form below:

Postal address: 220014, Minsk, per. S. Kovalevskaya, 52A

Phone: +375 (29) 674-35-58

E-mail: pv@ferane.by